Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/30

$3.11−0.11 (-3.42%)

Close on Nov 13, 2026Market cap $538.47MP/E –Yield –

Earnings

Entera Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Mar 26, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

–

EPS, Q3 FY2026

$0.11

$0.07 a year earlier

Latest guidance

Issued

Mar 8, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of Entera Bio's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q4 FY2026ended Dec 31, 2026	Mar 26, 2027Expected	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 6, 2026after the close	–	–	$0.11	Release
Q2 FY2026ended Jun 30, 2026	Aug 7, 2026after the close	–	–	-$0.14	Release
Q1 FY2026ended Mar 31, 2026	May 8, 2026after the close	–	–	-$0.07	Release
Q4 FY2025ended Dec 31, 2025	Mar 27, 2026after the close	–	–	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 14, 2025after the close	–	–	$0.07	Release
Q2 FY2025ended Jun 30, 2025	Aug 8, 2025after the close	–	–	-$0.06	Release
Q1 FY2025ended Mar 31, 2025	May 9, 2025after the close	$42.00K	–	-$0.06	Release
Q4 FY2024ended Dec 31, 2024	Mar 28, 2025after the close	–	–	–	Release
Q3 FY2024ended Sep 30, 2024	Nov 8, 2024after the close	$42.00K	–	-$0.08	Release
Q2 FY2024ended Jun 30, 2024	Aug 9, 2024after the close	$57.00K	–	$0.06	Release
Q1 FY2024ended Mar 31, 2024	May 10, 2024after the close	–	–	$0.05	Release
Q4 FY2023ended Dec 31, 2023	Mar 8, 2024after the close	–	–	–	Release
Q3 FY2023ended Sep 30, 2023	Nov 14, 2023before the open	–	–	$0.08	Release
Q2 FY2023ended Jun 30, 2023	Aug 11, 2023after the close	–	–	–	Release
Q1 FY2023ended Mar 31, 2023	May 5, 2023after the close	–	–	$0.08	Release
Q4 FY2022ended Dec 31, 2022	Mar 31, 2023after the close	–	–	–	Release
Q3 FY2022ended Sep 30, 2022	Nov 10, 2022after the close	$8.00K	–	$0.11	Release
Q2 FY2022ended Jun 30, 2022	Aug 11, 2022before the open	–	–	–	Release
Q1 FY2022ended Mar 31, 2022	May 12, 2022before the open	$68.00K	–	$0.13	Release
Q4 FY2021ended Dec 31, 2021	Mar 8, 2022before the open	–	–	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Entera Bio guided for has been reported

Guidance history

Every forecast Entera Bio put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Mar 8, 2022	operating loss	FY2022	$25.00M – $30.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.